Shasun Pharmaceuticals Ltd is planning to invest around Rs 250 crore in the next fiscal year, towards setting up its greenfield facility in Vizag and other regular capital expenditure. The company is raising around Rs 50 crore from Mauritius-based Caduceus Asia Mauritius Ltd, a part of healthcare private equity fund OrbiMed Advisors LLC. The company has started construction of its Vizag plant, in January this year, and expects to complete it with an investment of around Rs 100 crore. The plant is expected to be commissioned by October 2012. Shasun Pharmaceuticals informed the BSE that the company is planning to allocate 6,578,947 equity shares of face value of Rs 2 at a cash price of Rs 76 a share (including a premium of Rs 74 per share) aggregating to Rs 50 crore to Caduceus Asia Mauritius Ltd, Mauritius. With this, the Mauritius-based private equity firm would have 11.93 per cent stake in Shasun Pharmaceuticals.

 

The object of the issue is to raise long term funds for the company to part-finance the capital expenditure, long term working capital requirements. With the issuance of shares to the PE, promoters’ holding will come down to 41.15 per cent from the present 46.73 per cent. Financial institutions, mutual funds, banks and FII holdings will come down to 14.57 per cent from 16.54 per cent, public shareholding to 27.69 per cent from 31.44 per cent, foreign nationals to 0.35 per cent from 0.39 per cent, NRIs to 0.62 per cent from 0.70 per cent and corporate body to 3.69 par cent from 4.19 per cent.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×